3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
Research output: Contribution to journal › Journal article › Research › peer-review
This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.
| Original language | English |
|---|---|
| Journal | Circulation. Cardiovascular Interventions |
| Volume | 5 |
| Issue number | 8 |
| Pages (from-to) | 812-8 |
| Number of pages | 7 |
| ISSN | 1941-7640 |
| DOIs | |
| Publication status | Published - 2012 |
ID: 48477036